Roche to present new data from its industry-leading haematology portfolio at the American Society of Hematology 2018 Annual Meeting

Roche today announced that new data for its approved and investigational medicines across a range of blood diseases, and including several first-in-class medicines, will be presented at the 60th American Society of Hematology (ASH) Annual Meeting from 1-4 December, 2018.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news